Dr Reddy’s Joins Remdesivir Licensees
Firm Adds To Others That Have Struck Deals With Gilead
Dr Reddy’s has become the latest firm to strike a licensing deal with Gilead for its remdesivir potential treatment for COVID-19.

Dr Reddy’s has become the latest firm to strike a licensing deal with Gilead for its remdesivir potential treatment for COVID-19.